We examined the acute and sub-chronic toxicity of D-allose in rats. In the acute toxicity test, the calculated LD 50 value was 20.5 g/kg. In the sub-chronic toxicity test, no difference was found among the four groups in most of the serum chemical and hematological test results. These results suggest that D-allose is not toxic to rats.
Because of the very small amounts of D-allose in natural products, few studies of D-allose metabolism in animals have been conducted.
Recently, we developed a new method of producing D-allose enzymatically on a large scale.
1) D-Allose has been reported to have potential for use in the pharmaceutical industry, e.g., as an inhibitor of cancer cell proliferation 2) and in the production of reactive oxygen species from neutrophils.
3) It has been reported that D-psicose, a precursor of D-allose, suppressed hepatic lipogenic enzyme activity, reduced abdominal fat accumulation, 4, 5) provided no energy to growing rats, 6) inhibited intestinal -glucosidase activity, and suppressed the glycemic response, 7, 8) but D-allose has not been studied in a nutritional investigation.
In this study, we examined the effects of acute oral administration and sub-chronic (6 months) feeding of several levels of D-allose to rats to gather basic data regarding the safety of D-allose as a nutritional substrate.
All procedures involving animals were approved by the Experimental Animal Care Committee of Kagawa University. The values of test results were expressed as means AE SD. All data were analyzed by one-way ANOVA and the Tukey-Kramer test. Differences were considered statistically significant at p < 0:05.
In the acute administration test, male Wistar rats were obtained from Japan SLC (Shizuoka, Japan). The animals were caged individually in an automatically air-conditioned room (temperature, 22 AE 2 C; humidity, about 50%) with light from 08:00 to 20:00 h. The rats were fed CE-2, a commercial rodent diet (CLEA, Tokyo) before toxicity tests were done.
D-Allose was prepared from D-psicose with immobilized L-rhamnose isomerase 1) and diluted to a 50% water solution. Seven groups of four rats (5 week old) were fasted overnight from 22:00 h and were orally given D-allose in single doses of 15, 17, 19, 21, 23, and 25 g/kg of body weight using a stainless sonde attached to a 20-ml syringe. The rats were observed for 48 h after D-allose administration in order to track their condition and the number of deaths. LD 50 values were calculated from the number of deaths by the BehrensKarber method. The rats fasted 12 h after D-allose administration and were then given free access to CE-2 and water.
One rat receiving 17 g/kg, one rat receiving 19 g/kg, two rats receiving 21 g/kg, three rats receiving 23 g/kg, and four rats receiving 25 g/kg died within 48 h after administration. Three rats receiving 15 g/kg, three rats receiving 17 g/kg, one rat receiving 21 g/kg, three rats receiving 23 g/kg, and three rats receiving 25 g/kg suffered from diarrhea within 48 h after administration. The calculated LD 50 value was 20.5 g/kg body weight as determined by the Behrens-Karber method. This value is higher than the LD 50 value of sucralose (1,6-dichloro-1,6-dideoxy--D-fructofuranosyl-4-chloro-4-deoxy--D-galactopyranoside) at doses of 16 g/kg for mice and 10 g/kg for rats, 9) and D-psicose at doses of 16 g/kg for rats. 10) Some rats had diarrhea after D-allose administration. The cause of diarrhea was probably a rise in osmotic pressure in the large intestine caused by the absorption obstacle of D-allose. Debility by diarrhea may have been one cause of rat death. These results were seen in rats given high doses of D-psicose. 10) In the sub-chronic feeding test, four groups of eight rats (Ct, A0.3, A1, and A3) were fed CE-2 containing 0, 0.3, 1.0, and 3.0% D-allose, and were given free access to water for 6 months. The amount test carbohydrate was decided by reference to previous studies of sucralose and D-psicose. 9, 11) Body weight gain and food intake were recorded every day. After 6 months, the rats were fasted overnight from 22:00 h, and then sacrificed by exsanguinity under anesthetization with intraperitoneal sodium pentobarbital. Blood was collected from the abdominal aorta for clinical hematological analysis and to obtain serum for chemical analysis. The brain, heart, lungs, liver, pancreas, kidneys, adrenals, spleen, testicles, intra-abdominal adipose tissues, and hindlimb skeletal muscles were quickly removed and weighed. Serum samples were stored at À20 C until analysis. Serum glucose (Glu), insulin (IRI), triacylglycerole (TG), total cholesterol (T-Cho), HDL cholesterol (HDLCho), urea nitrogen (UN), uric acid (UA), creatinine (Crea), albumin (Alb) and total protein (TP) concentrations and glutamate oxaloacetate transaminase (GOT) and glutamate pyruvate transaminase (GPT) activities y To whom correspondence should be addressed. Tel: +81-87-891-3082; Fax: +81-87-891-3021; E-mail: matsuo@ag.kagawa-u.ac.jp were measured using kits (Glucose CII-Test, Triglyceride G-Test, Total Cholesterol E-Test, HDL Cholesterol E-Test, Urea Nitrogen B-Test, Uric Acid C-Test, Creatinine Test, A/G B-Test, and Transaminase CIITest, Wako, Osaka) and a Rat Insulin ELISA kit (Shibayagi, Tokyo). A blood hematological test was requested from SRL (Tokyo).
The final body weight, weight gain, food intake, and food efficiency for the each group of rats are shown in Table 1 . Body weight and weight gain were significantly lower in the A3 group than in the Ct group. Food efficiency was significantly lower in the A3 group than in the other groups.
Tissue weights are shown in Table 1 . The lungs were significantly lighter in the A3 group than in the Ct group. The soleus and gastrocnemius muscles were significantly lighter in the A3 group than in the Ct group. The plantaris muscle was significantly lighter in the A0.3 and A3 groups than in the Ct group. No significant differences were seen in the other tissues. In addition, no abnormality of the digestive tract was seen macroscopically in any group of rats. The serum chemical test results are shown in Table 2 . The serum Glu, IRI, TG, T-Cho, HDL-Cho, Crea, TP and Alb concentrations, and GOT activity were not significantly different among the four groups. The serum UN concentration was significantly lower in the A0.3 group than in the A3 group. The UA concentration was significantly higher in the Ct group than in the A1 group. GPT activity was significantly higher in the A0.3 group than in the A1 or the A3 group.
The hematological test results are shown in Table 2 . No significant differences were seen in any of the values, and all remained within normal ranges.
The sub-chronic test results suggest that body weight gain and food efficiency were suppressed by feeding of the 3% D-allose diet. Similar effects were seen in alterations in the weights of the lungs and skeletal muscles. Liver weights and hepatic enzyme activities in the D-allose-fed rats did not differ from those for the control rats. On the other hand, the class of rare sugars that includes D-psicose and D-tagatose have produced significant liver enlargement in chronic feeding studies with rats. 11, 12) Therefore, D-allose may have a different metabolic pathway and different physiological characteristics than these two rare sugars. Increasing the D-allose in the diet did not influence most serum chemical test and hematological test results. In addition, these test results remained within the range of normal values.
In conclusion, our results suggest that D-allose is not toxic to rats and displays nutritional characteristics different from other monosaccharides, such as D-glucose and D-fructose. However, detailed study is required to clarify the appropriateness of D-allose as a food.
